chapter 19 Flashcards

1
Q

Cells arise that no longer respond to normal growth control
mechanism and give rise to clones of cells to produce ________________________.

A

tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

benign tumors:

A

Not capable of indefinite growth and does not invade the healthy
surrounding tissue extensively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

malignant/cancerous tumor:

A

Continues to grow and becomes progressively invasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Small clusters of cancerous vessels dislodge from a tumor, invade the
blood or lymphatic vessels, and carried to other tissues, where they continue to proliferate

A

metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cancers are classified according to their ___________________origin

A

embryonic tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tumors that develop from epithelial origins

A

carcinomas
-skin, gut, epithelial linings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

derive from mesodermal connective tissue

A

sarcomas
-bone, fat, cartilage tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

derive from hematopoietic stem cells

A

lymphomas, myelomas, and leukemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

change that a normal cell undergoes as it becomes malignant

A

transformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What factors can induce transformation?

A

-radiation
-carcinogens (chemicals)
-viruses
-expression of oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

a gene that encodes a protein capable of inducing cellular transformation

A

oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how are oncogenes derived from viruses written compared to those derived in normal cells?

A

v-onc
c-onc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

proto-oncogenes:

A

enhance cell survival when their control mechanisms fail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

tumor-suppressor genes:

A

allow cancer cell survival when they fail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

________________gene problems can also lead to abnormal cell survival

A

apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is involved in induction of cellular proliferation?

A

-growth factors and receptors
-products involved in signal transduction

17
Q

what is involved in inhibition of cellular proliferation?

A

tumor suppressor genes

18
Q

What is Bcl-2 involved in?

A

regulation of apoptosis

19
Q

what is Burkitt’s lymphoma an example of?

A

DNA alterations/chromosomal translocations that induce malignant transformation

20
Q

Describe tumor-specific antigens (TSA):

A

-unique to tumor cells, don’t occur in normal cells
-may result from mutations that generate altered cellular proteins
-cytosolic processing of these proteins leads to novel peptides that are presented with Class I MHC
**uncommon

21
Q

Describe tumor-associated antigens (TAA):

A

-not unique to tumor cell
-may be antigens normally expressed on fetal cells, when immune systems cannot react to them
-not normally expressed on adult cells
**common

22
Q

Describe chemically or physically induced tumor antigens:

A

-Two carcinogens: Methylcholanthrene and UV light
-Tumor antigens can be distinct and the immune response to one tumor doesn’t protect against the other tumor

23
Q

Describe viral induced tumor antigens:

A

Viruses induced tumors express tumor antigens shared by all tumors induced by the same virus.

24
Q

Oncofetal tumor antigens:

A

Antigens appear early in embryonic development, before the immune system mature; if the antigens appears later on cancer cells, they are recognized as non-self and induce an immunologic responses

25
Q

Oncogen proteins as tumor antigens:

A

Breast cancer cells up-regulate oncogen-encode Neu protein, a growth factor receptor

26
Q

How are adaptive cell types involved in eradication?

A

-lack of T cells leads to increases in cancer
-Tumor-inflitrating lymphocytes (TILS) (T, NKT, NK)
-B cells generate anti-tumor antibodies against tumor-specific antigen
* Promotes tumor-cell recognition and lysis
–*May block CTL access to tumor Ag, though

27
Q

what are some immune responses to cancers?

A

-CD8 T cells recognize and kill cells that express foreign peptides
-antibodies target tumor antigens leading to complement activation and ADCC

28
Q

NK cells in response to cancer:

A

– Respond in the absence of MHC class I
– Can bind antibody-coated tumors leading to ADCC

29
Q

macrophages in response to cancer:

A

– Cluster around tumors leading to regression
– Not MHC restricted
– mediated ADCC
– Antitumor lytic enzymes and TNF-α

30
Q

The role of cytokines in controlling cancer:

A
  • IFN-γ
  • All interferon types enhance tumor-cell removal activities of
    immune cells
  • IL-12
    – Encourages DCs to activate strong TH1 and CTL responses
  • TNF-α may promote or inhibit anti-cancer effects; role in
    cancer immunity is complex
31
Q

How can enhancing anti-tumor antibodies promote cancer?

A

– May bind and block tumor Ag that would otherwise be targeted by
CTLs
– May form complexes with free tumor Ag

32
Q

active immunosuppresion in tumor microenvironments can promote cancer because?

A
  • Soluble factors released can suppress immunity
    – TGF-β
    – IL-10
    – Induction of TREG cells
33
Q

How do tumors evade the immune system?

A
  1. Reduced MHC expression in tumor cells
  2. Tumor cell subversion of apoptosis signals:
    -Upregulation of anti-apoptotic mediators
    -Expression of mutated or absent death receptors
  3. Tumor cells may provide poor costimulatory signals —leading to clonal anergy
34
Q

What are the 4 categories of cancer immunotherapy?

A

– Chemotherapies aimed at blocking DNA synthesis and cell division
– Hormonal therapies which interfere with tumor-cell growth
– Targeted therapies such as small molecule inhibitors of cancer
– Immunotherapies which induce or enhance the anti-tumor immune response

35
Q

what will be the benefit of harvesting and transfecting tumor cells with a gene for GM-CSF?

A

This cytokine will promote DC presentation of tumor Ag,
stimulating CTL responses

36
Q

what is it called when cancer cells develop their own blood supply?

A

angiogenesis